Meeting Coverage

APACT: Phase III Trial

APACT: Phase III, multicenter, international, open label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) alone for surgically resected pancreatic...

Read More